نتائج البحث - (( significant decrease decrease ) OR ( ((significance test) OR (significance testing)) decrease ))

بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significance testing » significance set (توسيع البحث)
significance test » significance set (توسيع البحث), significance level (توسيع البحث), significance _ (توسيع البحث)

1461

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1462

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1463

Comparison of Wmax (A), the changes in VE (B), and WVT (C) among the three oxygen conditions. حسب Kazufumi Hisamoto (21416905)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1464

Determination of the ventilatory threshold (VT) point. حسب Kazufumi Hisamoto (21416905)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1465

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1466

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1467

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1468

Comparison of SpO2 (A), HR (B), SBP (C), and DP (D) on VT among the three oxygen conditions. حسب Kazufumi Hisamoto (21416905)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1469

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1470

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the induction phase. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1471

Mean liver weight (g) (A), liver weight/body ratio (B), hepatic triglyceride (mg/g) (C) and hepatic steatosis quantification (% area) (D) upon completion of the treatment phase. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1472

Schematic overview of the experimental groups. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1473

Line graph illustrating mean food intake (in grams) at weekly intervals during the induction phase. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1474

Mean mesenteric, retroperitoneal, pericardial, and total visceral adipose tissue weights (in grams) upon completion of the experiment. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1475

Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1476

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1477

Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1478

Mean lipid profile (mmol/L) upon completion of the experimental period. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1479

Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:
1480

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... حسب Elsie D. Oduor (22521785)

منشور في 2025
الموضوعات:

أضف إلى المفضلة

محفوظ في:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Comparison of W<sub>max</sub> (A), the changes in V<sub>E</sub> (B), and W<sub>VT</sub> (C) among the three oxygen conditions. حسب Kazufumi Hisamoto (21416905)

Determination of the ventilatory threshold (VT) point. حسب Kazufumi Hisamoto (21416905)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Comparison of SpO<sub>2</sub> (A), HR (B), SBP (C), and DP (D) on VT among the three oxygen conditions. حسب Kazufumi Hisamoto (21416905)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the induction phase. حسب Elsie D. Oduor (22521785)

Mean liver weight (g) (A), liver weight/body ratio (B), hepatic triglyceride (mg/g) (C) and hepatic steatosis quantification (% area) (D) upon completion of the treatment phase. حسب Elsie D. Oduor (22521785)

Schematic overview of the experimental groups. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean food intake (in grams) at weekly intervals during the induction phase. حسب Elsie D. Oduor (22521785)

Mean mesenteric, retroperitoneal, pericardial, and total visceral adipose tissue weights (in grams) upon completion of the experiment. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. حسب Elsie D. Oduor (22521785)

Mean lipid profile (mmol/L) upon completion of the experimental period. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. حسب Elsie D. Oduor (22521785)

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... حسب Elsie D. Oduor (22521785)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Comparison of W<sub>max</sub> (A), the changes in V<sub>E</sub> (B), and W<sub>VT</sub> (C) among the three oxygen conditions. حسب Kazufumi Hisamoto (21416905)

Determination of the ventilatory threshold (VT) point. حسب Kazufumi Hisamoto (21416905)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Comparison of SpO<sub>2</sub> (A), HR (B), SBP (C), and DP (D) on VT among the three oxygen conditions. حسب Kazufumi Hisamoto (21416905)

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter حسب Katipot Inkong (7979942)

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the induction phase. حسب Elsie D. Oduor (22521785)

Mean liver weight (g) (A), liver weight/body ratio (B), hepatic triglyceride (mg/g) (C) and hepatic steatosis quantification (% area) (D) upon completion of the treatment phase. حسب Elsie D. Oduor (22521785)

Schematic overview of the experimental groups. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean food intake (in grams) at weekly intervals during the induction phase. حسب Elsie D. Oduor (22521785)

Mean mesenteric, retroperitoneal, pericardial, and total visceral adipose tissue weights (in grams) upon completion of the experiment. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean body weight (in grams) at weekly intervals during the induction phase. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean body weight (in grams) at weekly intervals during the treatment phase. حسب Elsie D. Oduor (22521785)

Mean lipid profile (mmol/L) upon completion of the experimental period. حسب Elsie D. Oduor (22521785)

Line graph illustrating mean food intake (g) at weekly intervals during the treatment phase. حسب Elsie D. Oduor (22521785)

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... حسب Elsie D. Oduor (22521785)

أدوات البحث:

تنقيح النتائج

المؤلف

سنة النشر